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Abstract
Various kind of chemical substances, including man-made chemical products and unintended products, are emitted to
ambient air. Some of these substances have been shown to be mutagenic and therefore to act as a carcinogen in
humans. National pollutant inventories (e.g., Pollutant Release and Transfer Registration in Japan) have estimated release
amounts of man-made chemical products, but a major concern is the release of suspended particulate matter containing
potent mutagens, for example, polycyclic aromatic hydrocarbons and related compounds generated by the combustion
of fossil fuel, which are not estimated by PRTR system. In situ exposure studies have revealed that DNA adducts in the
lung, and possibly mutations in germline cells are induced in rodents by inhalation of ambient air, indicating that
evaluating in vivo mutations is important for assessing environmental health risks. Transgenic rodent systems (Muta, Big
Blue, and gpt delta) are good tools for analyzing in vivo mutations induced by a mixture of chemical substances present
in the environment. Following inhalation of diesel exhaust (used as a model mixture), mutation frequency was increased
in the lung of gpt delta mice and base substitutions were induced at specific guanine residues (mutation hotspots) on
the target transgenes. Mutation hotspots induced by diesel exhaust were different from those induced by
benzo[a]pyrene, a typical mutagen in ambient air, but nearly identical to those induced by 1,6-dinitropyrene
contained in diesel exhaust. Comparison between mutation hotspots in the TP53 (p53) gene in human lung
cancer (data extracted from the IARC TP53 database) and mutations we identified in gpt delta mice showed
that G to A transitions centered in CGT and CGG trinucleotides were mutation hotspots on both TP53 genes
in human lung cancers and gpt genes in transgenic mice that inhaled diesel exhaust. The carcinogenic
potency (TD50 value) of genotoxic carcinogen was shown to be correlated with the in vivo mutagenicity
(total dose per increased mutant frequency). These results suggest that the mutations identified in transgenic
rodents can help identify environmental mutagens that cause cancer.
Keywords: Air pollutant, Environmental mutagen, Genotoxic carcinogen, In situ exposure, Lung, Mutation
hotspot, Polycyclic aromatic hydrocarbon, Risk assessment, Transgenic rodent gene mutation assay
Background
Various chemical substances, including man-made prod-
ucts and unintended products, have been and continue
to be emitted into the environment, such as ambient air,
water, and soil; of these environmental media, ambient
air is the major destination of pollutants. The Japanese
national inventory for the release of chemicals to the en-
vironment (Pollutant Release and Transfer Registration,
PRTR) [1] contains statistics of releases notified by
businesses (point sources) and the releases outside
notification (i.e., non-point sources, such as automobile
and household emissions) estimated by the government;
in the fiscal year 2014, about 90% of the total release of
man-made chemicals from point sources was emitted
into the air; even if the release from non-point sources
was included, it is estimated that 80% of the total release
was emitted into the air. PRTR also shows the release of
IARC/WHO (International Agency for Research on Can-
cer/World Health Organization) Group 1 substances
(categorized as human carcinogens), into the environ-
ment. For example, the release of benzene and 1,3-buta-
diene (1,3-BD) in fiscal year 2013 was estimated to be
7700 and 1500 t, respectively (including 7000 and
1300 t, respectively, emitted from non-point sources)
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[2]. These data indicate that measurable amounts of car-
cinogens are released to ambient air, although the annual
average concentrations of these substances in ambient
air were not over the environmental quality standard
(3 μg/m3 for benzene) and the guideline value (2.5 μg/
m3 for 1,3-BD) at any monitoring stations in urban areas
in Japan in fiscal year 2013 [3].
While the release of man-made chemicals has been
comprehensively estimated in industrial countries by gov-
ernments and non-governmental organizations, registra-
tion of the amount of unintended products released to the
environment is limited; for example, dioxins are the only
unintentionally-produced by-product whose release has
been registered in PRTR in Japan [2]. However, it is well-
known that various kinds of unintentionally-produced by-
products are generated by the combustion of fossil fuel,
for example, in automobile engines (such as diesel en-
gines) and in heating processes, and are emitted mainly to
ambient air as components of suspended particulate mat-
ter (SPM). Some unintended products in ambient air are
suspected to cause lung cancer and other respiratory dis-
ease, such as asthma [4–6].
The soot generated by combustion of coal was the
earliest-discovered air-born carcinogen; in the 18th cen-
tury, it was discovered that heavy exposure to soot
causes skin tumors in humans, and in the early 20th cen-
tury, benzo[a]pyrene (BaP), a polycyclic aromatic hydro-
carbon (PAH) contained in soot, was identified as a
carcinogen (for review, see [7]). In recent decades, some
PAHs, including nitrated PAHs, contained in SPM have
been shown to be genotoxic and have been categorized
as IARC Group 1 (e.g., BaP) or IARC Group 2A/2B (sus-
pected human carcinogens) [8]. For instance, the ex-
haust of diesel engines is classified as IARC Group 1 [9].
These facts indicate that mixtures of mutagenic and/or
carcinogenic combustion products have been released
into the air and inhaled by habitats in urban areas.
Epidemiological studies in the United States [10, 11]
and Japan [12] show an association between the inci-
dence of disease (lung cancer and respiratory disease)
and long-term exposure to air pollution including SPM
with a diameter below 2.5 μm (PM2.5). Recent investiga-
tions conclude that outdoor air pollution is classified as
IARC Group 1 [13]. However, the cancer risk of air pol-
lutant mixtures that contain mutagenic by-products of
combustion has only been evaluated on the basis of lim-
ited epidemiological data. To improve the health risk as-
sessment of whole air pollutants, it is necessary to
conduct experimental animal studies to quantitatively
evaluate how the exposure to a mixture of air pollutants
induces DNA damage, such as DNA adducts, that can
lead to in vivo mutagenesis and potentially carcinogen-
esis; furthermore, it is important to know whether such
air pollutants could induce mutations in germline cells.
Induction of DNA damage by inhalation of mutagens
The presence of mutagens in ambient air, especially in
SPM, has been surveyed in various countries by using in
vitro bioassay systems, such as the Ames test [14, 15].
Studies in Japan have shown that mutagens are ubiqui-
tously present in air-borne particles collected in large
cities [16]. Matsumoto et al. [17] reported that the con-
tents of the PM2.5 fraction collected at an intersection
with heavy traffic in Tokyo exerted higher mutagenicity
than did larger air-borne particles from the same loca-
tion. Watanabe et al. [18] showed that the soil in the
Kyoto area contained mutagenic compounds that might
be deposits from air, and identified the major mutagens
as nitrated PAHs such as 3,6-dinitrobenzo[e]pyrene. The
identification of various mutagens in ambient air indi-
cates that people inhale a mixture of various mutagens,
rather than a single mutagen.
Inhalation of a mixture of mutagens has been suspected
to induce DNA damage resulting in carcinogenesis in tar-
get organs and, in some cases, mutagenesis in the germ
cells. Although DNA adduct formation, micronucleus in-
duction, and DNA strand breaks in surrogate tissues, for
example white blood cells, have been analyzed as bio-
markers for assessing the genotoxicity of tobacco smoke
[19, 20], the total mutagenicity of the environmental mix-
ture in ambient air remains to be clarified. Formation of
DNA adducts has been shown to be elevated in the white
blood cells of individuals heavily exposed to air pollutants
[21]; however, the amount of DNA adducts induced in tar-
get tissues, especially lung, by air-borne chemicals needs
to be analyzed to assess the mutagenicity of the whole en-
vironmental mixture. Since analysis of DNA adducts in
lung tissue cannot be conducted for human populations,
studying the exposure of experimental animals, such as
rodents, to ambient air (in situ exposure), is a limited but
potentially effective method for addressing the issue of
how a whole mixture of air pollutants is mutagenic [22].
In situ exposure of experimental animals to ambient air
We conducted an in situ exposure study for a 60-week
period from 1996 to 1997 in which rats were maintained
in polluted air containing SPM with a diameter of
<11 μm at an average monthly concentration of 76.5 μg/
m3 (range 50.4–108.3 μg/m3). The rats were housed in a
small animal facility located beside an intersection with
heavy traffic in the Tokyo metropolitan area, and air was
circulated from the outside environment [23]. DNA ad-
duct analysis revealed that the levels of DNA adducts,
some of which were probably PAH–DNA adducts, were
elevated in lungs, nasal mucosa, and livers of rats after
exposure to urban air for 4 weeks, with the levels de-
creasing gradually during prolonged exposure over
12 weeks; these results indicate that urban air exerts
genotoxic effects not only directly in respiratory organs,
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such as lung and nasal mucosa, but also indirectly in tis-
sues remote from respiratory organs, such as liver. An in
situ exposure study in São Paulo showed induction of
micronuclei in peripheral erythrocytes of mice following
exposure to urban air for 90 days [24]. In an earlier in
situ exposure study, coke oven emissions containing
892 ng/m3 PAHs, as a model mixture of air pollution,
were shown to induce DNA adduct formation in the
lungs and non-respiratory tissues (heart, liver, and white
blood cells) of rats [25]. These results suggest that air
pollution in urban areas causes somatic mutations.
Analysis of mutagenesis not only in somatic cells but
also in germ cells has been a major issue in environmen-
tal mutagen research. In situ exposure to ambient air in
a polluted area near a steel mill in Canada in 1999
showed that the frequency of inheritable mutations at
expanded simple tandem repeat (ESTR) loci was signifi-
cantly higher in mice exposed to polluted ambient air
for 10 weeks compared to those in a non-polluted area
[26]; ESTR mutations are detected as a change in the
number of tandem repeats in the ESTR loci (e.g., Ms6-
hm). Interestingly, the elevation of heritable mutations
at the ESTR loci was originally observed in a herring gull
(Larus argentatus) population nesting in a polluted area
near steel mills [27, 28]. Somer et al. [29, 30] and Yauk
et al. [31] demonstrated that the frequency of ESTR mu-
tations in mice exposed to polluted air near steel mills
and a highway was 1.6 times higher than that of mice
exposed to air that was SPM depleted by high-efficiency
particulate arrestance (HEPA)-filtration at the same loca-
tion, indicating that SPM can potentially increase the
mutation frequency at ESTR loci. DNA strand breaks in
sperm and DNA-adduct formation in lung were also
found to be elevated in mice exposed to polluted air
containing total SPM (mean 93.8 ± 17.0 μg/m3) or PAHs
(mean 8.3 ± 1.7 ng/m3), for 3 or 10 weeks, respectively
[31]. These increases in heritable mutations at ESTR loci
suggest that exposure to air-borne particulates contain-
ing mutagens can cause germ cell mutations. An ele-
vated frequency of mutations at ESTR loci was also
observed in mouse sperm following exposure of the mice
to tobacco smoke (mainstream tobacco smoke [32] or
sidestream tobacco smoke [33]). Irradiation studies
showed that the average doubling dose of ESTR mutations
following low linear energy transfer (LET) irradiation of
spermatogonia or stem cells was 0.62–0.69 Gy [34]. How-
ever, the mechanism for inducing ESTR mutations is still
unknown, and further studies are required to resolve the
biological significance of ESTR mutations [34].
Transgenic rodents as a tool for analyzing in vivo
mutagenesis by air pollutants
The observations in the above in situ exposure studies
raise the question of whether DNA damage induced by
exposure to air pollutants becomes fixed as in vivo mu-
tations in the target tissues. To answer this question,
transgenic rodents (Muta, Big Blue, and gpt delta) are
useful, because they allow analysis of in vivo mutations
induced by environmental mutagens.
In the Muta, Big Blue, and gpt delta systems, a target
gene for detecting mutations (lacZ encoding E. coli β-
galactosidase, lacI encoding the E. coli lactose operon
repressor, or gpt encoding E. coli guanine phosphoribo-
syltransferase, respectively) carried on a λ phage shuttle
vector is integrated into the genomic DNA (for review,
see [35]). Transgenic mice, harboring genome-integrated
DNA plasmids containing the lacZ gene were also estab-
lished [36, 37]. After Muta, Big Blue, and gpt delta ro-
dents are exposed to mutagen, the shuttle vector is
rescued from the genomic DNA to host E. coli, and (1)
the mutated target gene is detected by phenotypic trans-
formation of the host E. coli, that is the appearance of β-
galactosidase-null plaques, β-galactosidase-expressing
plaques, and 6-thioguanine-resistant colonies, respect-
ively, (2) the cII gene on the λ phage shuttle vector can
also be used as the target gene (for review, see [35]), and
(3) the gpt delta system can be applied to detect large
deletions on genomic DNA.
Transgenic rodents have been used for the analysis of
in vivo mutagenicity of carcinogenic air-borne chemicals
such as 1,3-BD, ethylene oxide, and PAHs. For example,
inhalation of 1,3-BD at a concentration of 625 ppm by
Muta mice for 5 days accelerated in vivo mutagenesis in
lung but not in bone marrow or liver [38]. When Big
Blue mice were exposed to 1,3-BD at the same concen-
tration and for the same time period as that used for
Muta mice above, the results demonstrated that 1,3-BD
is mutagenic in bone marrow [39]. Recio et al. [39] pro-
posed that the difference in in vivo mutagenicity of 1,3-
BD in bone marrow between Muta mice and Big Blue
mice might be due to differences in 1,3-BD bioactivation
between the host strains (CD2F1 and B6C3F1, respect-
ively). Following 2-year inhalation exposure to 1,3-BD, an
increased incidence of neoplasms in the hematopoietic
system was shown in B6C3F1 [40]. Furthermore, when
Big Blue mice were exposed to 1,3-BD at a concentration
of 1250 ppm for 4 weeks, the frequency of mutations at
A:T pairs was significantly increased in bone marrow [41],
and the frequency of G to A transitions was significantly
increased at non-CpG sites in spleen [42, 43]. Formation
of persistent DNA adducts derived from 1,3-BD on aden-
ine residues [44] may contribute to the increased fre-
quency of mutation at A:T pairs. Elevation of in vivo
mutagenesis in lung by ethylene oxide was also demon-
strated by an inhalation study using Big Blue mice [45, 46].
The relative potencies of in vivo mutagenicity were com-
pared among PAHs administered by intraperitoneal (ip) in-
jection to Big Blue mice [47] or orally to Muta mice [48].
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The results indicated that in vivo mutagenicity in lung was
as high for dibenzo[a,l]pyrene as for BaP; however, whereas
G to T transversions and G to A transitions were the major
base substitutions induced in lung by dibenzo[a,l]pyrene,
G to T transversions were the sole major base substitution
induced in lung by BaP [47]. Our group’s intratracheal ad-
ministration studies showed that the mutant frequency in
vivo of 1,6-DNP [49] was about 20 times higher than that
of BaP [50]. These observations indicate that transgenic ro-
dent assay systems are a useful tool for analyzing in vivo
mutations induced in lung and other respiratory organs by
environmental chemicals inhaled from ambient air.
Analysis of in vivo mutagenesis induced by diesel exhaust
as a model mixture of air pollutants
By using various transgenic rodents, our group exam-
ined the in vivo mutagenicity of diesel exhaust emitted
from an engine. Diesel exhaust is an appropriate model
of air pollution in urban areas, because it is the major
source of genotoxic carcinogens, such as PAHs, as men-
tioned above. We showed that inhalation of diesel ex-
haust, at an SPM concentration of 6 mg/m3 for 28 days,
by Big Blue rats increased the mutant frequency, and el-
evated the level of DNA adducts, in lung [51]. In con-
trast, feeding of standard reference material of diesel
particles at a concentration 80 mg/kg body weight for
21 days increased the level of DNA damage in colon and
liver [52] and lung [53] of Big Blue rat, but did not ele-
vate in vivo mutagenicity in these organs.
Our inhalation study using gpt delta mice also demon-
strated that the frequency of in vivo mutation increased
in lung depending on the duration of exposure to diesel
exhaust at an SPM concentration of 3 mg/m3 [54]. The
mutant frequency was elevated to 2.11 ± 0.08 × 10−5 in
exposed mice compared with 0.82 ± 0.07 × 10−5 in con-
trol mice, after 24-weeks exposure. However, inhalation
of standard reference material of diesel particles for
90 min at a concentration of 80 mg/m3 on a single day
or 4 consecutive days did not elevate the in vivo mutage-
nicity in the lungs of Muta mice [55]. Our studies using
transgenic rodents demonstrate that diesel exhaust emit-
ted from an engine induces in vivo mutagenesis in lung,
whereas induction of micronuclei in reticulocytes was
not observed in mice and rats by exposure of diesel ex-
haust at the low concentration (about 30 μg/m3) for
3 months [56, 57].
Sequence analysis of mutated gpt genes rescued from
the diesel exhaust–exposed lungs of gpt delta mice re-
vealed that the most frequent type of base substitution
on gpt gene induced by exposure to diesel exhaust was
G to A transitions [58], and the next most common was
the G to T transversions. Mutation hotspots (mutation
loci identified from three or more mice) were present at
nucleotide numbers 64, 110, and 115 for G to A
transitions and 185, 401, 402, 406, and 418 for G to A
transitions and G to T transversions; this is recognized
as a molecular signature for mutation induced by oxida-
tive stress [59] or exposure to BaP in lung [50]. Since
nucleotide numbers 64 and 110 were sites of mutation
in non-exposed mice, the components in diesel exhaust
possibly enhanced the frequency of spontaneously-
induced mutations, but mutations at nucleotide numbers
185, 401, 402, 406, and 418 may be a unique signature
for exposure to diesel exhaust. Interestingly, these hot-
spots induced by diesel exhaust were different from
those induced by intratracheally-administered BaP, that
is G to T transversions at nucleotide numbers 125, 140,
143, and 413 [50], but similar to those induced by intra-
tracheally administered 1,6-DNP [49], suggesting that
components other than BaP in diesel exhaust were the
major inducers of in vivo mutagenesis in lung. Hotspots
of mutation in the livers of phenacetin-dosed gpt delta
rats, that is nucleotide numbers 26 and 416 [56], are dif-
ferent from those induced by exposure to diesel, 1,6-
DNP, or BaP. Therefore, hotspots of mutation in target
genes integrated into the genomic DNA of rodents are
potentially specific landmarks for identifying a type of
exposed mutagen.
Germline mutations induced by mutagens contained in
diesel exhaust
Following inhalation of diesel exhaust to gpt delta mice,
we observed an increase in the mutant frequency in
testis, but not in liver, suggesting that diesel exhaust or
mutagens in diesel exhaust might induce mutations in
male germline cells such as sperm [58]. However, this
observation contrasted with in vivo mutagenicity of a
heterocyclic amine, 2-Amino-1-methyl-6-phenylimi-
dazo[4,5-b]pyridine (commonly known as PhIP), which
induced mutations in liver but not in testis [60]. Any
mutagens in diesel exhaust may be specifically distributed
to the testis and induce mutations in this organ. Abnormal
morphology of sperm is reported to be correlated to the
level of air pollution in the human population of the
Czech Republic [61], but it is yet to be revealed whether
air pollution causes germline mutations.
Transgenic rodents are also a good model for evaluat-
ing induction of germline mutations. Administration of
a potent mutagenic alkylating agent, ethylnitrosourea or
isopropyl methanesulfonate, to Muta mice by a single ip
injection induced mutations in the lacZ target gene, and
genomic DNA rescued from seminiferous tubule germ
cells after a period of mutation expression for 52 days,
showed a significant increase in the mutant frequency in
germline cells [62]. When inherited germline mutations
induced by ethylnitrosourea were examined using gpt
delta mice, the frequency of inherited mutations in the
offspring of ethylnitrosourea-treated mice was 17-fold
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higher than that of the offspring of control mice [63]. A
longer expression period was required to detect muta-
tions in germline cells than somatic cells, because it
takes a prolonged period to fix mutagen-induced DNA
lesions in stem cells of germline as a mutation in differ-
entiated germline cells [64].
Regarding environmental mutagens, germ cell muta-
tions induced by BaP have also been examined in trans-
genic rodents. After transgenic mice bearing pUR288
lacZ were administered BaP by gavage at a dose of
13 mg/kg body weight 3 times per week for 6 weeks,
DNA adducts were induced in testis; however, the mu-
tant frequency increased in sperm but not in testis [65].
In contrast, an increased mutant frequency in sperm
was not observed in mice homozygous deficient for the
Xpc gene, which plays a role in the removal of bulky-
DNA adducts [65]. Formation of BaP–DNA adducts in
stem cell spermatogonia was shown to give rise to de
novo mutations in the sperm [66, 67], and exposure to
BaP in earlier life (5-days-old) induced elevated mutant
frequency in spermatogenic cells more effectively than
exposure to BaP in the adult stage [68]. A single-
molecule PCR method was established to measure in-
duction of mutations at ESTR loci [69]. Using this
method, administration of BaP by gavage at a dose of
100 mg/kg body weight for 28 days was shown to induce
ESTR mutations in the sperm of Muta mice [70].
Male germline mutations at ESTR loci were also en-
hanced in the offspring of female mice who inhaled
standard reference material of diesel particles [71] or
were subjected to irradiation by X-ray [72]. These obser-
vations suggest that BaP and other mutagens in diesel
exhaust could be germ cell mutagens. An interesting
comparative study has reported that one adduct forma-
tion of BaP has approximately the same mutagenicity as
10−4 Gy ɤ-irradiation [73]. Further studies, similar to those
for ethylnitrosourea [74], are required to quantitatively
evaluate germ cell mutagenesis induced by low-dose sub-
chronic exposure to BaP.
Mutation on Ras proto-oncogenes and TP53 (tumor
suppressor gene) in somatic cells by environmental
mutagens
Induction of somatic mutation(s) at specific sequences
on proto-oncogenes and/or tumor suppressor genes is a
key process in carcinogenesis. To reveal how mutation
at these specific sequences is induced by environmental
mutagens is an important issue for understanding the
mechanism of mutagenesis and carcinogenesis induced
by environment mutagens. Furthermore, mutations on
the unique sequences are candidate molecular signatures
for monitoring the exposure of mutagens.
Observations of mutations at codons 12, 14, or 61, of
Ras genes in human cancer have been well-documented
[75]. In chemical carcinogenesis studies, the Hras gene
was mutated at codon 61 in mouse hepatomas induced
by exposure to N-hydroxy-2-acetylaminofluorene, vinyl
carbamate, or 1′-hydroxy-2′,3′-dehydroestragole [76],
and analysis of DNA adduct formation revealed the
binding of benzo[a]pyrene diol epoxide (BPDE, reactive
intermediate of BaP) to guanine or adenine in codons 12
and 14 or of Kras gene in cultures of normal human
bronchial epithelial cells treated with BPDE [77].
In vivo mutagenesis of the Kras gene has been
analyzed by allele-specific competitive blocker PCR
(ACB-PCR). After Big Blue rats were treated with N-hy-
droxy-2-acetylaminofluorene, the frequencies of GGT to
GTT and GGT to GAT substitutions at Kras codon 12
in liver were 3.3 and 6.4 times, respectively, those in the
control, while transgenic rodent assay showed that G to
T transversion was the major base substitution induced
by N-hydroxy-2-acetylaminofluorene [78]. In contrast,
treatment of Big Blue rats with aristolochic acid signifi-
cantly increased the frequency of GAA to GTA substitu-
tions at Kras codon 61 in liver and kidney, but did not
induce GGT to GAT substitution at Kras codon 12 [79].
The frequencies of GGT to GTT and GGT to GAT sub-
stitution at Kras codon 12 were elevated by inhalation of
ethylene oxide at 100 ppm and 50–200 ppm, respect-
ively, for 4 weeks, but this effect was not observed
following inhalation for 8 weeks [80]; the authors specu-
lated that negative selection against cells carrying Kras
mutations occurred at the high cumulative dose of ethyl-
ene oxide. The results suggest that environmental muta-
gens induce mutations site-specifically on the Kras gene.
Mutations in the TP53 (p53) tumor suppressor gene
are frequently observed in human cancer [81, 82]. The
IARC TP53 database [83] compiles data on TP53 muta-
tions detected in human cancer, and provides useful
information for understanding the mechanism of car-
cinogenesis. Analysis of this database reveals that the
TP53 gene is mutated frequently at several specific co-
dons in cancer. For example, in BPDE-treated HeLa cells
and bronchial epithelial cells, BPDE–DNA adducts fre-
quently form at commonly mutated codons in the TP53
gene (codons 157, 248, and 273) [84], suggesting that a
unique mutation spectrum was induced by each muta-
gen on the TP53 gene. To compare the TP53 mutation
spectra produced by various environmental mutagens,
human p53 knock-in (Hupki) mouse lines were estab-
lished and an in vitro assay for detecting mutations in-
duced on the human TP53 gene was developed [85]. In
the Hupki mouse genome, the DNA-binding domain of
the mouse Trp53 (Tp53) gene has been replaced with
the normal human TP53 gene by using gene-targeting
technology. For the in vitro assay, cultures of Hupki
mouse–derived embryonic fibroblast (HUF) cells were
treated with chemical substances; immortalized cells
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were obtained following several passages of treated cells;
and the humanTP53 gene in the immortalized cells was
subjected to sequencing.
Treatment of HUF cells with BaP frequently induced
mutations including G to T transversions (a landmark
mutation of BaP exposure) on codons 157, 158, and 273
of the TP53 gene; these correspond to positions fre-
quently mutated in human lung cancer [86, 87]. A po-
tent mutagen present in diesel exhaust particles, 3-
nitrobenzanthrone, induces G to T transversions in HUF
cells [88]. In HUF cells treated with aristolochic acid, an
A to T transversion is induced in codon 139, which is
registered as a frequently mutated site in the IARC p53
mutation database [89]. Taken together, these observa-
tions indicate that HUF cells are potentially useful for
identifying mutagen-specific mutation sites on the TP53
gene, and thus can be used to reveal the mechanisms by
which environmental mutagens cause carcinogenesis.
TP53 gene mutation in lung cancer and molecular signature
induced by inhalation of environmental mutagens
Inhalation of mutagens is recognized to cause lung can-
cer, and air pollutants and tobacco smoke are suspected
to be major causes of in vivo mutagenesis of proto-
oncogenes and tumor suppressor genes in lung. Among
proto-oncogenes and tumor-suppressor genes, TP53 is
frequently mutated gene in lung cancer; about 40% of all
lung cancer cases compiled in the IARC TP53 database
[83] carry a mutated TP53 gene. A unique characteristic
of TP53 mutation in lung cancer is a high rate of occur-
rence of G to T transversions; this rate is comparable to
that of G to A transitions, which are common mutations
in the TP53 gene in all types of cancer, including lung
[81, 90]. The frequently mutated codons (hotspots) on
the TP53 gene in lung cancer are codons 157, 158, 175,
245, 248, 249, and 273 [91].
G to T transversion is a base substitution induced not
only by administration of BaP via formation of BPDE-
DNA adducts [50, 92] but also by generation of reactive
oxygen species via formation of 8-oxo-deoxyguanine
[93, 94]. Because the lung is an organ directly in con-
tact with air, it is reasonable to expect that G to T
transversions that are induced by exogenous agents
such as PAHs or oxygen would occur frequently in lung
cancer. Mutation spectrum analysis has shown that the
rate of G to T transversions in the lung cancer of
smokers (about 30%) is higher than that of non-
smokers (10%–15%) [90, 91, 95]. However, experimen-
tal inhalation of environmental tobacco smoke to Big
Blue mice showed that the most common mutation in-
duced on the cII gene was G to A transition and the
next was G to T transversion [96].
I analyzed the IARC TP53 database to reveal the mu-
tation spectrum at the level of nucleotide sequence of
the TP53 gene in lung cancer, and potentially identify
agent(s) contributing to mutagenesis of the TP53 gene.
Table 1 summarizes my analysis of the base substitutions
in frequently mutated codons in the TP53 gene in lung
cancer [91]. It is well-known that mutations are mainly
induced at CpG sites on the TP53 gene in human cancer
[81]. As shown in Table 1, G to T transversions were in-
duced in lung cancer on 5 guanine residues centered in
CGN triplets at nucleotide #12457 of codon 157 (CGT
to CTT), #12461 of codon 158 (CGC to CTC), #13370
of codon 245 (CGG to CTG), #13380 of codon 248
(CGG to CTG), and #13799 of codon 273 (CGT to
CTT). The triplets (CGC, CGT, and CGG), in which G
to T transversions were induced in the TP53 gene, were
identical to those containing the BaP-induced mutation
hotspots (nucleotide numbers 125, 140, 143, and 413 on
the gpt gene) in the lungs of gpt delta mice [50]. These
observations confirm the speculation that G to T trans-
versions on mutated TP53 genes in lung cancer may be
induced by BaP and other carcinogenic PAHs contained
in tobacco smoke [90, 91, 97].
G to A transitions were also frequently induced in
lung cancer. G to A transitions were induced at 4 guan-
ine residues, that is, at nucleotide #12512 of codon 175
(CGC to CAC), #13380 and #13381 of codon 248 (CGG
to CAG), and #13799 of codon 273 (CGT to CAT).
Among these triplets, guanine residues centered in CGT
and CGG were also mutation hotspots for G to A transi-
tions induced by inhalation of diesel exhaust in the lungs
of gpt delta mice (nucleotide numbers 64, 110, and 115
of the gpt gene) [54]. Again, these findings indicate that
air pollutants emitted from diesel engines and other fos-
sil fuel combustion processes may contribute, at least
partly, to mutagenesis of the TP53 gene, but the possibil-
ity that spontaneous mutations were enhanced on fre-
quently mutated codons on TP53 gene cannot be ruled
out, because G to A transitions occur frequently as
spontaneous mutations. Nevertheless, it is clear that
comparison between the mutation spectra of proto-
oncogenes and tumor suppressor genes in lung cancers
and those of in vivo mutations in transgenic rodent as-
says can provide clues to the identify of environmental
mutagens that cause cancer.
Correlation between in vivo mutagenicity and
carcinogenicity
As mentioned above, transgenic rodents are a good tool
for evaluating the potential of environmental chemicals
to induce mutations in vivo. However, more investiga-
tion is required to reveal the relationship between the
potencies of in vivo mutagenicity and carcinogenicity.
Suzuki [98] reported that TD50 (value of chronic dose-
rate [mg/kg body weight/day] that would induce tumors
in half the test animals at the end of a standard lifespan
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[99]) was associated with fold-increase in mutant fre-
quency in transgenic rodents per total dose administered
to the animals. Recently, Ono and Honma [100]
presented the possibility that BMDL10 (the lower 95%
confidence bound on the benchmark dose corresponding
to 10% specific change) of carcinogenicity can be
Table 1
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predicted from the BMDL10 of mutagenicity in the trans-
genic rodents. Therefore, it is important to precisely
analyze the relationship between in vivo mutagenicity in
the transgenic rodent assay and the carcinogenicity of
various chemicals.
For this purpose, I extracted dose–response data for
carcinogenicity from the Carcinogenic Potency Database
(CPDB) [99], which contains the dose–response data for
1547 chemicals; and I obtained data on in vivo mutage-
nicity of 163 chemicals in transgenic rodent assays from
the published literature [35]. At the Annual Meeting of
Japanese Environmental Mutagen Society in 2009 [101],
based on preliminary data, I put forward the hypothesis
that TD50 values of genotoxic carcinogens correlate to
the values of in vivo mutagenic potency if compared for
the same target organ and administration route. Because
the TD50 value in CPDB is the harmonic mean calcu-
lated from the TD50 value of the most potent target site,
in the current study I obtained TD50 values of genotoxic
carcinogens in liver and lung for each route of adminis-
tration (inhalation, oral gavage or diet, or ip injection)
by calculating harmonic means of the values cited in
CPDB except benzene (see Additional file 1). I defined
in vivo mutagenic potency as the harmonic mean of the
total dose of agents administered to an animal (total
dose) divided by the induced mutant frequency (the mu-
tant frequency of the treatment group minus the mutant
frequency of the control group) × 105 (IMF); the values
for total dose and IMF used for this calculation were ex-
tracted from reference [35].
The criteria of dose–response data used for calculation
of TD50 in mouse liver and lung were as follows: 1)
dose–response data with two or more doses were used,
and if this was not available, one-dose data were used; 2)
if more than one tumor type was induced in the organ,
data from the various tumor types was combined for the
calculation; 3) if dose–response data with two or more
doses were used, the dose–response curve that was con-
sistent with linearity (marked as ‘*’ in CPDB) was used
for the calculation; 4) the data in CPDB were evaluated
as showing positive carcinogenicity (marked as c or + in
the database); 5) the number of animals per group was
over ten, 6) the incidence of tumors in the control and
the elevation of incidence in treatment groups was
below 40% and over 10%, respectively; and 7) the signifi-
cance of the correlation of dose–response was P < 0.10.
For calculating in vivo mutagenic potencies, total doses
obtained by multiple-time dosing cited in reference [35]
were used, except for total dose for inhalation, which
was re-calculated as indicated in Additional file 1. The
calculated values of the harmonic means of TD50 and
total dose/IMF (T/I) of each chemical and the data
for calculating these values are listed in Table 2 and
Additional file 1, respectively.
I analyzed whether the harmonic mean values of
TD50 of mouse liver or lung correlated to T/I values
(in vivo mutagenic potencies). As shown in Fig. 1, log
[harmonic mean of TD50] (hereafter, log TD50) was
linearly related to log [harmonic mean of T/I] (here-
after, log T/I), suggesting that carcinogenicity of geno-
toxic carcinogens could be predicted from the target
and route-matched in vivo mutagenicity. This linear
correlation between log TD50 and log T/I was an un-
expected finding, since the carcinogenicity of a geno-
toxic substance can be affected by the substance’s
tumor promoting activity. Among various in vitro
assay systems for predicting carcinogenicity, the Bhas
assay, which uses a clone of BALB/c 3 T3 cells trans-
fected with the v-Ha-ras gene, is an established sys-
tem for evaluating the tumor promoter activity. The
tumor promoter activity of several substances listed in
Table 2 have previously been tested by Bhas assay; 2,4-dia-
minotoluene and urethane (ethyl carbamate) were evalu-
ated to be negative, but 2-acetylaminofluorene was
positive [102], indicating that, even if a genotoxic carcino-
gen possesses tumor promoter activity, the plots of car-
cinogenicity (log TD50) vs. in vivo mutagenicity (log T/I)
show linearity. This observation suggests that the carcino-
genicity of chemical substances that exert in vivo mutage-
nicity in the transgenic mouse system could be mainly
driven by the mutagenicity (tumor initiator activity), at
Table 2 Harmonic means of TD50 values and total dose/IMF (T/
I; potency of in vivo mutagenicity) values of genotoxic carcinogens














2,4-diaminotoluene (diet) 26.7 1688
dichloroacetic acid (diet) 155 66867
MeIQ (diet) 27.1 272




urethane (diet) 39 427
Lung benzene (inhalation) 175 4937







urethane (diet) 28.3 303
The data for calculating these values are listed in Additional file 1
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least, in liver. However, the mechanistic basis of this linear
relationship remains to be further studied.
As a case study, the TD50 value of diesel exhaust was
estimated from the harmonic mean of the T/I values
(i.e., 105) in our study [58] (see Additional file 2). In a
previous study, Ichinose et al. [103] demonstrated that the
incidence of tumor in mouse lung was significantly ele-
vated 3.1-fold by intratracheal administration of diesel ex-
haust particle at the dose of 0.1 mg/animal, repeatedly 10
times at weekly intervals, comparing with the vehicle con-
trol. Using the formula of the relationship between the
carcinogenic potency and in vivo mutagenicity (Fig. 1), I
estimate the TD50 of diesel exhaust to be 17 mg/kg/day
(0.51 mg/animal/day, if body weight is 0.03 kg).
Conclusions
By using transgenic rodent assay systems, one can detect
mutations induced on genomic DNA at the level of al-
terations in the nucleotide sequence. These assay sys-
tems are a good tool for evaluating in vivo mutagenicity
induced by inhalation of air pollutants, especially a
whole mixture of air pollutants. Merits of these assay
systems are that they enable 1) analysis of the mutation
spectrum (the types of mutation, e.g., transition, trans-
version, or deletion, and their positions on the genome),
and 2) quantitative measurement of the potency of in
vivo mutagenicity in somatic cells and germ cells.
I therefore propose that 1) comparisons between the nu-
cleotide sequences of mutation hotspots induced in som-
atic cells by exposure to mutagens and the frequently
mutated nucleotide sequences on proto-oncogenes and
tumor suppressor genes may provide information about
the identify of mutagen(s) causing cancer; and 2) a linear
relationship exists between log TD50 (carcinogenicity)
and log T/I (in vivo mutagenicity), suggesting that car-
cinogenicity can be predicted from in vivo mutagenicity in
the target organ of cancer. Data suggesting that air pollut-
ants induce mutations on germ cells, as well as somatic
cells, have been presented; however, further studies are re-
quired to assess the potency of mutation in germ cells from
in vivo mutagenicity data. Recently, a high-throughput
method for analyzing the mutation spectrum of target
genes has been developed by using a next-generation se-
quencer [104, 105]. Novel technologies will strength a po-
tential of transgenic rodent assay systems for assessing the
carcinogenic risk of environmental mutagens.
A part of this review was presented in a lecture of
JEMS Award 2016 in the Annual Meeting of Japanese
Environmental Mutagen Society in 2016.
Additional files
Additional file 1: The data for calculating TD50 and T/I. Parentheses:
route of administration. Pathology: ade, adenoma; hpa, hepatoadenoma;
hpc, hepatocarcinoma; hpt, hepatoma; mal, malignant tumor; mix, more
than one tumor type; MXA, more than one tumor type, combined by
National Cancer Institute/National Toxicology Program [99]. Transgenic
Strain: BB, Big Blue mouse; Muta, Muta mouse; gpt, gpt delta mouse; Lac
Z plasmid, transgenic mouse harboring plasmids containing the lacZ
gene [36, 37].
#TD50 for benzene calculated from the data [106] by the procedure
of CPBD. 300 ppm × 1/3 (1 week exposure followed by 2 weeks
non-exposure) = 100 ppm. Incidence of lung adenoma in the
exposed group and non-exposed group: 26% (15/54) and 7% (3/46),
respectively. Concentration of benzene corresponding to 50%
increased incidence (incidence of lung adenoma, 54%) = 250 ppm.
250 ppm × 78.11 (molecular weight)/24.45 L (standard volume) = 0.8 mg/L.
0.8 (mg/L) × 0.03 L/min (inhalation volume) × 60 (min) x 6 h/day
(hours of inhalation per day/0.03 kg (body weight) = 288 mg/kg/day.
Duration of exposure: 81 weeks. Life time of mouse: 104 weeks.
TD50 = 288 × (81 weeks/104 weeks)
2 = 175 mg/kg/day.
The total doses were re-calculated at the conditions in the references
cited in [35].
*benzene. 300 ppm × 78.11 (molecular weight)/24.45 (L, standard
volume) = 0.96 mg/L.
0.96 (mg/L) × 0.03 L/min (inhalation volume) × 60 (min) x 6 h/day
(hours of inhalation per day)/0.03 kg (body weight) × 5 days
Fig. 1 Plot of log [harmonic mean of TD50] (log TD50) vs log [harmonic mean of T/I] (log T/I) calculated by a statistical package in Excel 2010
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(inhalation days per a week) × 12 weeks (duration of inhalation) =
20,736 mg/kg.
**1,3-butadiene. 625 ppm × 54.09/24.45 = 1.38 mg/L. 1.38 × 0.03 ×
60 × 6/0.03 × 5 days (duration of inhalation) = 2,500 mg/kg.
***ethylene oxide. 200 ppm × 44.05/24.45 = 0.36 mg/L. 0.36 × 0.03 ×
60 x 6/0.03 × 5 × 4 = 2,600 mg/kg. (XLSX 19 kb)
Additional file 2: Estimation of T/I for diesel exhaust. T/I of diesel
exhaust was estimated based on our data [53]. (DOCX 13 kb)
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